Literature DB >> 27448425

Effect of Biological Therapy on the Risk of Sleep Apnea in Patients with Psoriasis.

Alexander Egeberg1, Lone Skov1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27448425      PMCID： PMC4990957          DOI： 10.5664/jcsm.6144

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN： 1550-9389            Impact factor:   4.062


× No keyword cloud information.
  4 in total

1.  Bidirectional Relationship between Obstructive Sleep Apnea (OSA) and Psoriasis: Implications for OSA Therapies?

Authors:  Madhulika A Gupta; Fiona C Simpson; Aditya K Gupta
Journal:  J Clin Sleep Med       Date:  2016-09-15       Impact factor: 4.062

2.  Psoriasis and Sleep Apnea: A Danish Nationwide Cohort Study.

Authors:  Alexander Egeberg; Usman Khalid; Gunnar Hilmar Gislason; Lotus Mallbris; Lone Skov; Peter Riis Hansen
Journal:  J Clin Sleep Med       Date:  2016-05-15       Impact factor: 4.062

3.  Improvement in aspects of sleep with etanercept and optional adjunctive topical therapy in patients with moderate-to-severe psoriasis: results from the PRISTINE trial.

Authors:  D Thaçi; R Galimberti; M Amaya-Guerra; T Rosenbach; D Robertson; R Pedersen; S Yang; M Kuligowski; R Boggs
Journal:  J Eur Acad Dermatol Venereol       Date:  2013-07-15       Impact factor: 6.166

4.  Association Between Changes in Coronary Artery Disease Progression and Treatment With Biologic Agents for Severe Psoriasis.

Authors:  Kasper Fjellhaugen Hjuler; Morten Bøttcher; Christian Vestergaard; Hans Erik Bøtker; Lars Iversen; Knud Kragballe
Journal:  JAMA Dermatol       Date:  2016-10-01       Impact factor: 10.282
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.